Overview

The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC)

Status:
Withdrawn

Trial end date:
2022-09-01

Target enrollment:

Participant gender:

Summary

This study seeks to exploit bladder cannabidiol receptors as a therapeutic drug target by conducting a double-masked, placebo-controlled randomized trial evaluating the effects of vaginal hemp cannabidiol (CBD) suppositories on lower urinary tract symptoms (LUTS), pain severity, and sexual function.

Phase:

Phase 1

Details

Lead Sponsor:

University of New Mexico

Treatments:

Cannabidiol
Epidiolex